Putting the award page together from the records…
Putting the award page together from the records…
Hoffmann-La Roche Inc. received this contract from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $69.87M obligated so far for health r&d services; health care services; experimental development. It runs to 2028-12-31.
Key facts · data as of Oct 23, 2026
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award HHSO100201600038C, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_HHSO100201600038C_7505_-NONE-_-NONE-
Hoffmann-La Roche Inc.: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys
IGF::OT::IGF HOFFMANN-LAROCHE INC.
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
9 actions since 2023-04-13. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-08-10 | P00017 | Supplemental agreement (work within scope) | $8.10M | THE PURPOSE OF THIS MODIFICATION IS ADD SUPPLEMENTAL FUNDING FOR 0002 AND TO UPDATED THE PERIOD OF PERFORMANCE (POP) FOR CLIN 0001 TO END ON 12/31/2028. |
| 2025-09-25 | P00016 | Supplemental agreement (work within scope) | $13.75M | THE PURPOSE OF THIS MODIFICATION IS ADD SUPPLEMENTAL FUNDING FOR CLIN 0001 & 0002 AND TO UPDATED THE PERIOD OF PERFORMANCE (POP) FOR CLIN 0001 TO END ON 12/31/2026. |
| 2025-06-24 | P00015 | Administrative change | $0 | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE COST SHARE AMOUNT, EXTEND POP, UPDATE SOW, AND ADD SUPPLEMENTAL FUNDING TO CLIN 0002. |
| 2025-05-01 | P00014 | Supplemental agreement (work within scope) | $4.65M | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE COST SHARE AMOUNT, EXTEND POP, UPDATE SOW, AND ADD SUPPLEMENTAL FUNDING TO CLIN 0002. |
| 2025-02-14 | P00013 | Supplemental agreement (work within scope) | $29.10M | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE COST SHARE AMOUNT AND ADD SUPPLEMENTAL FUNDING TO CLIN 0002. |
| 2024-07-29 | P00012 | Supplemental agreement (work within scope) | $3.00M | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE COST SHARE AMOUNT AND ADD SUPPLEMENTAL FUNDING TO CLIN 0002. |
| 2024-05-24 | P00011 | Supplemental agreement (work within scope) | $9.27M | THE PURPOSE OF THIS MODIFICATION IS A NO COST EXTENSION, DE-OBLIGATE CANCELLING FUNDS, UPDATE COST SHARE AMOUNT, AND ADD SUPPLEMENTAL FUNDING TO CLIN 0002. |
| 2023-07-26 | P00010 | Supplemental agreement (work within scope) | $2.00M | THE PURPOSE OF THIS MODIFICATION IS THE ADDITION OF SUPPLEMENTAL FUNDING OF $2,000,000 TO SUPPORT SOURCE DATA VERIFICATION, FULL ELECTRONIC MEDICAL RECORD UPLOADS, AND THE ADJUDICATION PROCESS FOR THE ONGOING REFERENCE RANGE AND CLINICAL PERFORMANCE |
| 2023-04-13 | P00009 | Supplemental agreement (work within scope) | $0 | THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE EXCESS AND CANCELLING FUNDS |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗